Comments
Commented by Armin Schulz on March 23rd, 2023 | 07:58 CET
Manuka Resources starts gold production. Can Varta and K+S manage the turnaround?
On March 22, all eyes were on the FED decision. Will the balancing act between fighting inflation and stabilizing the banking system succeed? The collapse of Silicon Valley Bank and the difficulties of Credit Suisse have caused plenty of uncertainty. The result has been significant premiums in the price of gold and cryptocurrencies as people try to protect their money. But regardless of the interest rate decision, there is interesting news on companies that have been under pressure recently and are waiting for a turnaround. We take a look at three of those candidates today.
Read
Commented by Stefan Feulner on March 23rd, 2023 | 07:54 CET
RWE, Myriad Uranium, Cameco - The best environment ever
The geopolitical events of 2022 have heightened concerns about the security of supply and, combined with the ongoing focus on climate change, have created transformative tailwinds for the nuclear power industry. While Germany's last three nuclear reactors face shutdown, major industrialized nations are relying on zero-carbon nuclear power. As a result, the uranium price should be poised for a brilliant comeback after a bear market that has lasted for years.
Read
Commented by André Will-Laudien on March 22nd, 2023 | 10:49 CET
A new banking crisis in 2023? Deutsche Bank, Blackrock Silver, Commerzbank - Gold and Silver are back!
Central bankers are currently in a huge dilemma. They should fight the price pressure with a tough interest rate policy and gradual withdrawal of liquidity. However, this increases the existing risk of recession and the danger of a new financial crisis worldwide. In fact, past interest rate restrictions have already left grinding marks in the US banking system because gigantic write-downs on price losses still lie dormant in the books of institutions that had believed in eternally low interest rates. After the collapse of Silicon Valley Bank and the forced takeover of Credit Suisse, uncertainty has again taken a stranglehold on the markets. Gold and silver reacted with a giant leap. We look at the current situation.
Read
Commented by Nico Popp on March 22nd, 2023 | 10:42 CET
Subsidies beckon, shareholders profit: Volkswagen, NEL, First Hydrogen
Money from the state comes in handy for many companies. This is especially true when the challenges are great, and the capital requirements are immense. For large industrial companies, subsidies have always been part of the package. Just recently, Volkswagen, for example, picked up money in South Carolina. We explain in which industries there is also something "to be had" for shareholders.
Read
Commented by Fabian Lorenz on March 22nd, 2023 | 09:45 CET
Buffett adds to oil stocks: Shell, Saturn Oil + Gas, BYD
Star investor Warren Buffett has long been a fan of oil stocks. So it is no surprise that he is taking advantage of the current weak oil price to add to his favourite stock (after Apple): Occidental Petroleum. Berkshire Hathaway now holds around 23% of the US oil producer. Those looking to take advantage of the low oil price opportunity should also look at Shell and Saturn Oil & Gas. Numerous analysts recommend Shell and Saturn Oil & Gas is on its way to becoming a well-known producer after several spectacular takeovers. There is also news on BYD. Also a favourite of Buffett, but it is currently in a difficult market environment. Here is what recent media reports suggest.
Read
Commented by Stefan Feulner on March 22nd, 2023 | 09:00 CET
Barrick Gold, Globex Mining, First Majestic Silver - The resurgence of precious metals
In uncertain times, gold is considered a safe haven and enjoys great popularity among investors. Due to the banking industry's irregularities and Silicon Valley Bank's bankruptcy, a shift from the risky stock market to the precious metals sector was already apparent. This was further reinforced by the wobbling of Credit Suisse. With the crossing of a prominent resistance, the yellow metal is now striving for new highs.
Read
Commented by Nico Popp on March 21st, 2023 | 09:40 CET
Bank quake? Time to think outside the box! Commerzbank, Manuka Resources, Deutsche Bank
What a week! Eight days ago, we mentioned Credit Suisse as the supposed crisis bank and speculated: "It is quite possible that there will be a consolidation of the industry in the next few weeks and that problem banks will be taken over by market competitors." You know the result. But what does this mean for investors? We think one step further!
Read
Commented by André Will-Laudien on March 21st, 2023 | 08:39 CET
Goodbye banks - the Greentech rally is on: Shares of BYD, Canadian North, Mercedes Group and BMW are in focus!
Blunt, clear text - that is what the Intergovernmental Panel on Climate Change had promised, in case governments still did not get it. The latest "State of the World Report" is clear. Hesitation is a thing of the past. The message: action is needed now and must be taken worldwide. This is the conclusion of the so-called synthesis report of the Intergovernmental Panel on Climate Change (IPCC), which was presented yesterday in Interlaken, Switzerland. Leading scientists have spent the past week wrestling with more than 650 government representatives to lay things out as transparently as possible. The conclusion is quickly formulated: Full throttle for the Greentech industry!
Read
Commented by Stefan Feulner on March 21st, 2023 | 08:37 CET
Varta, Aspermont, Rheinmetall - Full speed ahead for expansion
Changing conditions in terms of broken supply chains, high raw material prices and an uncertain geopolitical situation have put many companies in dire straits since the Corona pandemic, leading to a collapse in sales and liquidity bottlenecks. Nevertheless, few managed to adapt their business models to emerge stronger from the crisis.
Read
Commented by Stefan Feulner on March 20th, 2023 | 09:37 CET
Evotec, Defence Therapeutics, Morphosys - Movement in the biotech sector
Is a new wave of takeovers starting in the biotech sector? Already last year, acquisitions by Big Pharma were expected to increase, but these largely failed to materialize. However, this could accelerate in the current year. On the one hand, pharmaceutical companies, such as vaccine manufacturer Pfizer, have deep pockets and need new innovations for their product portfolio; on the other hand, second-tier stocks are attractive targets due to the strong correction.
Read